关注
Srija Mukherjee
Srija Mukherjee
Dept of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur
在 iitk.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
In silico study identifies RO 28-2653 as a novel drug against SARS-CoV2 mutant strains
S Mukherjee, S Paul
International Journal of Computational Biology and Drug Design 14 (6), 457-480, 2021
32021
Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution
S Dey, P Pahari, S Mukherjee, JB Munro, DK Das
Structure, 2024
12024
SARS-CoV-2 spike fusion peptide trans interaction with phosphatidylserine lipid triggers membrane fusion for viral entry
P Singh, P Pahari, S Mukherjee, S Karmakar, M Hoffmann, T Mandal, ...
Mbio 15 (9), e01077-24, 2024
12024
A new insight to medicinal chemistry: docking study of repurposing drugs against SARS- COV2
SMS Paul
Covid 19 Pandemic: A comprehensive understanding, 2021
2021
系统目前无法执行此操作，请稍后再试。
文章 1–4